Artemis Medicare Services Limited

NSEI:ARTEMISMED Stock Report

Market Cap: ₹25.0b

Artemis Medicare Services Valuation

Is ARTEMISMED undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of ARTEMISMED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ARTEMISMED?

Other financial metrics that can be useful for relative valuation.

ARTEMISMED key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.3x
Enterprise Value/EBITDA24.6x
PEG Ratio1.3x

Price to Earnings Ratio vs Peers

How does ARTEMISMED's PE Ratio compare to its peers?

The above table shows the PE ratio for ARTEMISMED vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average37.1x
INDRAMEDCO Indraprastha Medical
21.6xn/a₹24.3b
SHALBY Shalby
37.4x24.0%₹30.2b
YATHARTH Yatharth Hospital & Trauma Care Services
41.1x25.7%₹38.4b
524520 KMC Speciality Hospitals (India)
48.4xn/a₹14.8b
ARTEMISMED Artemis Medicare Services
54.9x43.1%₹25.1b


Price to Earnings Ratio vs Industry

How does ARTEMISMED's PE Ratio compare vs other companies in the IN Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.1%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.1%
n/an/an/a
No more companies


Price to Earnings Ratio vs Fair Ratio

What is ARTEMISMED's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ARTEMISMED PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio54.9x
Fair PE Ratio69.8x


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.